hansoh glp-1 Merck pays $112M upfront for Hansoh's preclinical Merck & Co. signs license

Notably, the study by Petkovic-Dabic et al

Cost sensitivity is a leading driver of medication abandonment across chronic conditions, including obesity and diabetes 4

But when it comes to supporting body composition and sustainable weight management, the two can actually complement each other in powerful ways

Buse JB, Garber A, Rosenstock J, Schmidt WE, Brett JH, Videbk N, et al

Symptoms I Pay Attention To Unusual fatigue Rapid heart rate New digestive issues Anxiety or restlessness Drastic changes in hunger Red Flags Patients Often Ignore Feeling extremely cold Consistent brain fog Dramatic hair shedding No weight loss after 12+ weeks These can signal dose adjustments for thyroid medication, not a problem with GLP-1